Humana Is Quietly Becoming the Largest Medicare Advantage Insurer in America

Humana added 1.3 million MA members in 2026 while UnitedHealth shed 647,000 — the two companies are now neck-and-neck at ~7.1M vs ~9.2M enrollees. CenterWell's value-based care vertical is scaling fast with 60-70 new primary care centers planned this year, and the company is rolling out Google Cloud-powered AI across 80 million annual member calls.

HUM · Health Care · July 19, 2026

S&P 500 Position

Fourth-largest U.S. health insurer by revenue behind UnitedHealth Group (~$450B+ market cap), Elevance Health (~$110B), and Cigna Group (~$95B). Within managed care specifically, Humana is the most concentrated pure-play on Medicare Advantage — over 73% of Insurance premiums come from Individual MA, compared to more diversified books at UNH and Elevance. CVS/Aetna is the nearest MA-focused competitor with 4.1M+ enrollees. The concentration creates both leverage and fragility: Humana is disproportionately exposed to CMS rate-setting, star rating methodology changes, and Medicare policy shifts.

Index Weight: ~0.09% | Rank: Approximately #180-220 in the S&P 500 by market cap ($48B)

Company Overview

Humana is executing a land grab in Medicare Advantage. The company added 1.3 million MA members in 2026 — the largest absolute enrollment gain in the market — while UnitedHealth exited 109+ net counties and shed 647,000 members. Humana now holds 19.8% of the national MA market with 7.1 million enrollees, closing fast on UnitedHealth's 9.2 million (26% share). Healthcare Dive has flagged that UNH's projected year-end membership of 7.2-7.3 million could leave the two companies functionally tied. Combined, UNH and HUM control 46% of all MA enrollees nationwide. The strategic differentiator is CenterWell, Humana's vertically integrated healthcare services arm. CenterWell Senior Primary Care is now the nation's largest senior-focused, value-based primary care provider — 350 clinics across 15 states at end-2025, with 60-70 new centers planned for 2026. The February 2026 MaxHealth acquisition (54 owned clinics, 120,000+ patients in West and South Florida) and November 2025 Villages Health deal accelerated geographic density in Humana's most concentrated MA market (Florida accounts for ~20% of Individual MA premiums at $17.8B). CenterWell grew patient volume 25%+ in 2025 and added another 110,500 patients in Q1 2026 alone. The star ratings problem remains the elephant in the room. Only 20% of Humana's MA members sit in plans rated 4 stars or above (average: 3.61), compared to 78% at UnitedHealthcare and 55% at Elevance. Low star ratings directly reduce CMS quality bonus payments, compressing margins on the very membership Humana is racing to accumulate. Management is targeting a return to top-quartile ratings for 2027, but the delta with competitors is structurally significant.

Products & Revenue

Humana runs two reportable segments. The Insurance segment — Individual Medicare Advantage, Group MA, Medicaid, military (TRICARE), commercial, and specialty — generates the overwhelming majority of revenue through premiums. Individual MA alone accounted for $90.4B of the $123.8B in Insurance premiums and services in FY 2025. CenterWell is the healthcare delivery vertical: senior primary care clinics, home health, pharmacy, and behavioral health. CenterWell's external revenue is modest (~$1.4B in Q1 2026), but intersegment revenue from serving Humana's own members was $4.7B in Q1 — making CenterWell's true economic footprint much larger than the external number suggests.

Insurance — Individual Medicare Advantage (~61%): The core business. $90.4B in FY 2025 premiums/services. 6.39M members as of Q1 2026 (up 22.6% YoY). Florida is the single largest state market at ~$17.8B in premiums.

Insurance — Group Medicare Advantage (~6%): Employer-sponsored MA plans. $9.0B in FY 2025. Serves retirees of large employers and state/municipal pension plans.

Insurance — Military (TRICARE) (~estimated portion of remaining Insurance): Managed care for 4.6 million active-duty, retiree, and dependent military beneficiaries under the TRICARE East Region contract.

Insurance — Medicaid & Other (~estimated portion of remaining Insurance): State Medicaid managed care in markets including Michigan, Illinois, and South Carolina. Membership rose ~50,000 in Q1 2026 from new state program wins.

CenterWell (~15% (FY 2025: $22.47B total, 15.28% of consolidated)): Vertically integrated healthcare services: 350+ senior primary care clinics, home health and hospice (pre-Gentiva divestiture), pharmacy, and behavioral health. Q1 2026 revenue hit $6.1B (+19.7% YoY). Most revenue is intersegment — CenterWell serves Humana's own insurance members.

Based on FY 2025 10-K segment data (Insurance: $124.56B, CenterWell: $22.47B) and Q1 2026 10-Q filed with SEC. Individual MA and Group MA breakdowns from Humana's 2025 Annual Report.

Leadership

Jim Rechtin

CEO since 2024. Joined Humana in January 2024 as President and COO, promoted to CEO in July 2024. Previously led large-scale healthcare operations. His strategic agenda centers on the Insurance-CenterWell integration thesis: capturing MA membership at scale and routing those members into Humana-owned value-based care, which produces better outcomes and lower medical costs.

Aaron Martin, Insurance Segment President: Joined January 2026 after serving as VP Healthcare at Amazon (March 2022–December 2025). His Amazon background in consumer-facing healthcare products and logistics is directly relevant to Humana's push to modernize member experience and scale digital-first engagement.

Celeste Mellet, Chief Financial Officer: Overseeing the capital allocation strategy during a period of aggressive CenterWell expansion, the $1B subordinated notes offering, and the Gentiva stake divestiture.

John Barger, President of Medicare Advantage (incoming): 30-year industry veteran, currently President of Medicaid and Dual Eligible programs. Will formally assume the MA presidency upon George Renaudin's retirement in Q3 2026. Barger inherits the MA book at a critical moment — membership is surging but star ratings lag competitors.

Robert S. Field, Board of Directors (elected April 2026): Principal and Managing Member of ηMed Capital Management, a healthcare-focused investment firm specializing in managed care. His board appointment signals investor-class governance alignment during Humana's growth-over-margin phase.

The AI Angle

AI for 80 Million Calls and Clinical Burnout

Humana's highest-profile AI deployment is Agent Assist, built on Google Cloud's Vertex AI and Gemini foundation models. The system is designed to serve 20,000+ member advocates handling up to 80 million annual inbound calls. The pilot launched in October 2025 and full rollout across all member service centers is planned for 2026. This is a buy-not-build strategy — Humana is leveraging Google's managed AI infrastructure rather than training proprietary large language models, which makes sense for a company whose core competency is insurance operations, not model research. On the clinical side, CenterWell is running a scaled ambient AI pilot inside its primary care clinics. The system passively captures physician-patient conversations and generates structured clinical documentation, targeting the administrative burden that drives physician burnout. As of early 2025, the pilot was processing approximately 90,000 visit minutes per week, and physicians self-reported lower cognitive strain and burnout. CenterWell has identified roughly 20 AI use cases beyond ambient documentation, though specifics on the other 19 are not public. In CenterWell Home Health, Humana deployed AI solutions to improve clinical documentation and reduce administrative tasks for home-visiting clinicians. This sits alongside a broader operational restructuring that consolidated branch locations and centralized key functions — the AI layer is designed to maintain care quality while reducing per-visit overhead in a margin-sensitive business. The competitive context matters. UnitedHealth's Optum unit recently reported that AI trimmed its medical cost ratio by 270 basis points — a claim that, if sustained, represents a massive structural advantage. Humana has not disclosed comparable MLR-impact metrics for its AI programs. The risk is clear: if UNH's AI-driven cost management widens the gap, Humana's star rating deficit and thinner margins become harder to close even as membership scales. Humana's AI investments are real and operationally deployed, but they are primarily focused on member experience and clinician efficiency rather than the core actuarial engine.

Financial Snapshot

Revenue (TTM): $137.2B — TTM (ending March 31, 2026) | Net Income: $1.13B — TTM

Margins: Net margin 0.8% — thin even by managed care standards, reflecting the insurance segment's benefit ratio of 89.4% and heavy CenterWell expansion costs

Humana is trading at a substantial premium to managed care peers, priced for the MA enrollment inflection and CenterWell's scaling trajectory. Capital allocation is aggressive: the company repurchased $103M in shares in Q1 2026 at an average price of $182.13 (well below the current $400), has $2.72B remaining under its $3B buyback authorization, and is paying a $0.885/share quarterly dividend ($107M in Q1). The Gentiva divestiture (~$900M expected in Q3 2026) will recycle capital from hospice into the higher-growth primary care expansion. Full-year 2026 guidance: revenues ≥$160B (+23.4% YoY), Adjusted EPS ≥$9.00, though GAAP EPS guidance was cut to ≥$8.36 from ≥$8.89.

1-Year Performance

Current price $400.00. YoY performance data unavailable, but HUM shares rallied approximately 49.9% YTD through late June 2026, dramatically outperforming the managed care industry's 8.2% gain.

The rally was driven by three catalysts: the massive Q1 2026 MA enrollment beat (6.39M members, +22.6% YoY), UnitedHealth's self-inflicted membership contraction creating a market share vacuum, and the Q1 earnings beat ($10.31 Adjusted EPS vs. $9.96 consensus). Multiple analyst upgrades in July — Truist and RBC both raised targets to $415, Wells Fargo upgraded to Overweight — sustained momentum. The GF Value estimate of $367.67 suggests the stock is now running ahead of intrinsic value models, but the bull case rests on Humana potentially becoming the #1 MA insurer by enrollment within 12-18 months.

Recent News

Fun Fact: Humana was not originally a health insurance company at all. David Jones Sr. and Wendell Cherry founded it in 1961 as Extendicare, a nursing home chain. By the mid-1970s it had become the world's largest hospital company, operating over 80 hospitals. The name changed to Humana Inc. in 1974. The entire insurance business — which today generates $125B+ in annual revenue — was launched in 1985 as a secondary line to fill the company's own hospital beds. The tail swallowed the whale: Humana divested all its hospitals in 1993 (spinning them off as what became Kindred Healthcare) and went all-in on managed care.